Literature DB >> 16531369

Experimental models of temporary normothermic liver ischemia.

H U Spiegel1, R Bahde.   

Abstract

Hepatic ischemia/reperfusion injury has so far been investigated in various experimental models. A clinical transfer of experimental results is, however, problematic because of anatomical and physiological differences and also the inevitable simplification of experimental work. The choice of model must therefore be adapted to the clinical question to be answered. The simplest procedure for inducing normothermic ischemia is to clamp the hepatoduodenal ligament. Models that do not avert portal congestion are regarded as unsuitable. Our current understanding of the pathogenesis of ischemia/reperfusion injury depends mainly on studies whose authors have investigated either global liver ischemia with a portocaval shunt, spleen transposition and in the isolated perfused system, or partial ischemia. This review is a critical examination of various approaches to the study of normothermic hepatic ischemia in experimental animals.

Entities:  

Mesh:

Year:  2006        PMID: 16531369     DOI: 10.1080/08941930600569704

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  10 in total

1.  Hibernation reduces cellular damage caused by warm hepatic ischemia-reperfusion in ground squirrels.

Authors:  Jessica P Otis; Amanda C Pike; Jose R Torrealba; Hannah V Carey
Journal:  J Comp Physiol B       Date:  2017-01-31       Impact factor: 2.200

2.  Activation of different neuronal phenotypes in the rat brain induced by liver ischemia–reperfusion injury: dual Fos/neuropeptide immunohistochemistry.

Authors:  J Bundzikova; Z Pirnik; L Lackovicova; B Mravec; A Kiss
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

3.  Effect of liver ischemia-reperfusion injury on the activity of neurons in the rat brain.

Authors:  Zdeno Pirnik; Jana Bundzikova; Tomas Francisty; Elena Cibulova; Lubica Lackovicova; Boris Mravec; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.046

4.  Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model.

Authors:  Imam H Shaik; Jancy M George; Thomas J Thekkumkara; Reza Mehvar
Journal:  Pharm Res       Date:  2008-07-15       Impact factor: 4.200

5.  Effects of hepatic ischemia-reperfusion injury on the P-glycoprotein activity at the liver canalicular membrane and blood-brain barrier determined by in vivo administration of rhodamine 123 in rats.

Authors:  Mohammad K Miah; Imam H Shaik; Ulrich Bickel; Reza Mehvar
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

Review 6.  Autophagy and liver ischemia-reperfusion injury.

Authors:  Raffaele Cursio; Pascal Colosetti; Jean Gugenheim
Journal:  Biomed Res Int       Date:  2015-03-15       Impact factor: 3.411

7.  Age-related differences in function and structure of rat livers subjected to ischemia/reperfusion.

Authors:  Małgorzata Trocha; Anna Merwid-Ląd; Małgorzata Pieśniewska; Joanna Kwiatkowska; Lidia Fereniec-Gołębiewska; Przemysław Kowalski; Adam Szeląg; Tomasz Sozański
Journal:  Arch Med Sci       Date:  2018-02-21       Impact factor: 3.318

8.  Preserving low perfusion during surgical liver blood inflow control prevents hepatic microcirculatory dysfunction and irreversible hepatocyte injury in rats.

Authors:  Chong-Hui Li; Yong-Wei Chen; Yong-Liang Chen; Li-Bin Yao; Xin-Lan Ge; Ke Pan; Ai-Qun Zhang; Jia-Hong Dong
Journal:  Sci Rep       Date:  2015-09-24       Impact factor: 4.379

9.  Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure.

Authors:  Mohammed Al-Saeedi; Niels Steinebrunner; Hassan Kudsi; Niels Halama; Carolin Mogler; Markus W Büchler; Peter H Krammer; Peter Schemmer; Martina Müller
Journal:  Cell Death Dis       Date:  2018-01-26       Impact factor: 8.469

10.  Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemia.

Authors:  Tom S Chan; Shamir Cassim; Valérie-Ann Raymond; Sven Gottschalk; Grégory Merlen; Claudia Zwingmann; Pascal Lapierre; Peter Darby; Cyril David Mazer; Marc Bilodeau
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.